TGF-β1 of no avail as prognostic marker in lyme disease
Background. Within the present in vivo study using the wild type mouse strains C3H/HeN and FVB/N it was intended to (1) measure TGF-β1 expression in the course of lyme disease, (2) examine the potential correlation of TGF-β1 expression with the clinical outcome of a Borrelia infection (with a focus...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2014-05-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/398.pdf |